Main > RHEUMATOLOGY > Rheumatoid Arthritis > Treatment > Co.: DE. B. BioSimilar AdalimuMAb

---

Co.: DE. B. BioSimilar AdalimuMAb's subsections
(*) USA Approval Date: 2017. 08.29
Company
TradeMark

Co.: DE. B. BioSimilar AdalimuMAb's products
This section has no products